Clinical trial · Observational
Splenic Hilar Nodes in Splenic Flexure Cancer
Aberrant Lympahtic Drainage of Splenic Flexure Cancer: Are Splenic Hilar Nodes Metastases an Underecognized Phenomenon?
NCT04666883CI-TRIAL-00049170unknownClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
Report the incidence of metastases to the splenic hilar lymphnodes from splenic flexure primaries. This mode of spread has not been previously characterized for these tumours.
Conditions
Conditions (2)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Colon Cancer | Malignant Colon Neoplasm | CURATED_EXACT | 0.92 |
| Metastases, Lymphatic | — | UNRESOLVED | — |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| Review of records and follow up | Other | — | UNRESOLVED |
Design
Arms and outcomes
Arms (1)
- label
- Splenic flexure cancer patients
- description
- Splenic flexure cancer patients
- interventionNames
- Other: Review of records and follow up
Primary outcomes (1)
- measure
- Splenic hilum nodal metastases
- timeFrame
- 5 years
- description
- Splenic hilum nodal metastases
Eligibility
Eligibility (as posted)
- Sex
- All
Show eligibility criteria text
Inclusion Criteria: * All splenic flexure cancer patients Exclusion Criteria: * No consent to data utilization
References
Publications (0)
Data not yet available
No reference posted for this study.